$76.73+29.02% · 3M
Moving avg
1W+4.65%
1M+12.00%
3M+27.08%
6M-6.08%
YTD-5.40%
1Y+3.31%
3Y-18.79%
5Y-29.77%
52-week range
$58.8958% of range$89.83
Company health
Value2/6
Growth3/6
Profitability4/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (284%)
Risks
- Richly valued at 59.7x earnings
Key statistics
Valuation
Market cap
$14.96B
Enterprise value
$16.07B
P/E ratio (TTM)
59.75x
P/S ratio (TTM)
3.25x
EV/EBITDA
18.56x
Per share & returns
EPS (TTM)
$1.21
Dividend yield
0.00%
Beta (1Y)
0.84
30-day change
+12.00%
Trading
Volume (24h)
0
Previous close
$76.82
Shares outstanding
195.03M
About The Cooper Companies, Inc.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Symbol
COO
The Cooper Companies, Inc. is a large-cap healthcare company in the Medical - Instruments & Supplies industry. Its shares are listed on NASDAQ (United States) and trade under the ticker COO.
Frequently asked questions
What is The Cooper Companies, Inc.'s market cap?
The Cooper Companies, Inc. (COO) has a market capitalization of $14.96B.
What is The Cooper Companies, Inc.'s P/E ratio?
The Cooper Companies, Inc. trades at a price-to-earnings (P/E) ratio of 59.75.
What exchange does COO trade on?
COO trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 365.50-0.92%
$357.62B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 124.20-1.32%
$290.17B cap
AstraZeneca PLCLON: AZN
£117.02-1.20%
$244.86B cap